文献速递性腺与生殖内分泌垂体与肾上腺疾病

女性11-氧合C19类固醇不随年龄下降

11-Oxygenated C19 Steroids Do Not Decline With Age in Women.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该研究比较了100例绝经前(20-40岁)和100例绝经后(≥60岁)女性的19种类固醇谱,发现DHEA、DHEAS、A4和T随年龄下降,但11-氧合雄激素不下降,且11OHT/T和11OHA4/A4比值与年龄正相关。肾上腺皮质结构变化可能解释这一现象。

要点

  • 绝经后女性DHEA、DHEAS、A4和T显著低于绝经前,但11-氧合雄激素不随年龄下降。
  • 11OHT/T和11OHA4/A4比值与年龄呈强正相关。
  • 老年肾上腺网状带退化导致HSD3B2和CYB5A分区模糊,可能解释雄激素谱变化。

核心结论

  • 与DHEA、DHEAS、A4和T不同,11-氧合雄激素在衰老女性中不下降。
  • 肾上腺皮质结构变化可能解释衰老女性雄激素谱的演变。

研究设计与样本

  • 研究纳入100例绝经前(20-40岁)和100例绝经后(≥60岁)女性,采用液相色谱-串联质谱法测定晨血清19种类固醇。
  • 对8例绝经前和8例绝经后女性正常肾上腺组织进行HSD3B2与CYB5A或SULT2A1的双重免疫荧光分析。

主要发现

  • DHEA、DHEAS、A4和T在绝经前女性中分别显著高于绝经后女性2.9、2.8、2.9和1.6倍(P < 0.0001)。
  • 11-氧合雄激素不随年龄下降,11OHT/T和11OHA4/A4比值与年龄呈强正相关(r = 0.5和0.8,P < 0.0001)。
  • 老年肾上腺网状带退化,HSD3B2和CYB5A的清晰分区变得模糊,出现重叠区域。

临床怎么用

  • 临床评估绝经后女性雄激素状态时,除DHEA、DHEAS、A4和T外,应考虑11-氧合雄激素不随年龄下降的特点。
  • 11OHT/T和11OHA4/A4比值随年龄升高,或可作为反映肾上腺雄激素输出变化的指标。

局限性

  • 研究样本量有限(类固醇测定各100例,免疫荧光各8例),结论需更大样本验证。
  • 仅测定晨血清类固醇,未评估其他时间点或组织局部浓度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The ovaries and adrenals are sources of androgens in women. Although dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and testosterone (T) all decline with age, these C19 steroids correlate poorly with parameters of androgen action in postmenopausal women. OBJECTIVE: To comprehensively compare the androgen profiles of pre- and postmenopausal women. METHODS: We quantified 19 steroids-including DHEA; DHEAS; T; androstenedione (A4); and the following adrenal-specific 11-oxygenated C19 steroids (11oxyandrogens): 11β-hydroxytestosterone (11OHT), 11-ketotestosterone (11KT), 11β-hydroxyandrostenedione (11OHA4), and 11-ketoandrostenedione (11KA4)-using liquid chromatography-tandem mass spectrometry in morning serum obtained from 100 premenopausal (age 20 to 40 years) and 100 postmenopausal (age ≥ 60 years) women. Double immunofluorescence of 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) with cytochrome b5 (CYB5A) or sulfotransferase 2A1 (SULT2A1) was performed in normal adrenal glands obtained from eight premenopausal and eight postmenopausal women. RESULTS: DHEA, DHEAS, A4, and T were significantly higher in pre- than in postmenopausal women (2.9, 2.8, 2.9, and 1.6-fold, respectively; P < 0.0001). In contrast, the 11-oxyandrogens did not decrease with aging, and the 11OHT/T and 11OHA4/A4 ratios showed strong positive correlations with age (r = 0.5 and 0.8, respectively; P < 0.0001). Double immunofluorescence analysis showed that with the involution of the zona reticularis in the old adrenals, the sharp zonal segregation of HSD3B2 and CYB5A becomes less distinct, and areas of HSD3B2 and CYB5A overlap are observed. CONCLUSIONS: Unlike DHEA, DHEAS, A4, and T, the 11oxyandrogens do not decline in aging women. Structural changes within the adrenal cortex might explain the evolution of androgen profiles in aging women.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Nanba AT, Rege J, Ren J, et al. 11-Oxygenated C19 Steroids Do Not Decline With Age in Women. J Clin Endocrinol Metab. 2019. PMID: 30753518. doi:10.1210/jc.2018-02527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。